Skip to main content
NewslettersWatchlist

Terrascend Corp(TSND-T)
TSX

Today's Change
Real-Time Last Update
Day Low1.01
Day High1.14
Open:1.09
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Healthcare Sector Stocks on TSX (TSND)
GlobeNewswire
TerrAscend Reports Third Quarter 2024 Financial Results
GlobeNewswire
TerrAscend Enters Ohio with the Signing of Definitive Agreement to Acquire a Well Situated and Profitable Dispensary
GlobeNewswire
TerrAscend to Host Third Quarter 2024 Earnings Conference Call
GlobeNewswire
TerrAscend Closes on Remaining US$26 Million Draw of US$140 Million Debt Financing
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Drug Manufacturers Industry Stocks (TSND)
AI-generated - The Globe and Mail
TerrAscend: Top 25 Undervalued Toronto Stock Exchange Stocks (TSND)
GlobeNewswire
TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Drug Manufacturers Industry Stocks (TSND)
GlobeNewswire
TerrAscend Announces $10 Million Share Repurchase Program
GlobeNewswire
TerrAscend Completes $140 Million Debt Financing
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Small Cap Stocks on TSX (TSND)
GlobeNewswire
TerrAscend to Host Second Quarter 2024 Earnings Conference Call
GlobeNewswire
TerrAscend Announces Results of Annual General Meeting
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Small Cap Stocks on TSX (TSND)
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Small Cap Stocks on TSX (TSND)
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Drug Manufacturers Industry Stocks (TSND)
AI-generated - The Globe and Mail
TerrAscend: Top 10 Undervalued Drug Manufacturers Industry Stocks (TSND)
GlobeNewswire
TerrAscend Announces May Conference Participation
The Globe and Mail
Monday’s analyst upgrades and downgrades
GlobeNewswire
TerrAscend to Host First Quarter 2024 Earnings Conference Call
GlobeNewswire
TerrAscend to Host Fourth Quarter and Full Year 2023 Earnings Conference Call

Profile

TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.